Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ELVN | Enliven Therapeutics, Inc. | Chief Medical Officer | $0 | -$526K | -100% | Oct 18, 2024 |
IOBT | IO Biotech, Inc. | Director | Jun 6, 2024 | |||
KURA | Kura Oncology, Inc. | Director | Jun 5, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|